CN

Gene Synthesis

mMPS Microchip-Based High Throughput Gene Synthesis

Leveraging proprietary high-throughput DNA synthesis instruments and automated operation stations, GCATbio has established an automated and modulized DNA synthesis platform. This automated platform has filed 31 patents, with 5 patents granted and 20 software copyrights registered. Additionally, GCATbio has spearheaded and published a total of 6 international, national, and local standards related to gene synthesis.

Utilizing the mMPS high-throughput synthesis technology, this platform enables the parallel operation of massive microchips, achieving high-quality synthesis of a single DNA sequence on each microchip. This technology significantly reduces DNA synthesis costs while increasing yield by a factor of 10,000 to the pmol scale, helping you explore infinite possibilities.

Key Benefits

Cost-effectiveness

Compared to nmol-scale column-based synthesis and fmol-scale chip-based synthesis, mMPS technology enables a significant reduction in cost per base while increasing yield to pmol scale to meet diverse needs.

High Fidelity

With high-throughput synthesis, the error rate is reduced to 1:1000 nt;100% verified by high-throughput sequencing

Highly Automated Assembly

The mMPS synthesis technology significantly simplifies the gene assembly process, leading to an increased assembling success rate

What Do We Offer?

Clonal Genes

Cloning of synthesized DNA into a plasmid vector,followed by high-throughput sequencing verification

Gene Fragments

Synthesis of linear double-stranded DNA fragments